HORIZON
CARE1
First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma
- Programme
- Horizon Europe
- Started
- Ends
- Duration
- 60 months
- Total cost
- EUR 5,577,694
- EU contribution
- EUR 5,577,694
- Participants
- 16 from 8 countries
- Topic
- HORIZON_HORIZON-MISS-2022-CANCER-01-03
- Grant agreement
- 101104801
Coordinated by Institut Gustave Roussy (FRFrance).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Institut Gustave Roussy | FRFrance | Coordinator | EUR 2,084,688 | PIC (1.00) |
| Medizinische Universitaet Wien | ATAustria | Participant | EUR 251,600 | PIC (1.00) |
| Fakultni Nemocnice Olomouc | CZCzechia | Participant | EUR 288,000 | known name (0.95) |
| Universitaetsklinikum Essen | DEGermany | Participant | EUR 579,000 | PIC (1.00) |
| Fundacio Privada Institut D'Investigacio Oncologica de Vall-Hebron (Vhio) | ESSpain | Participant | EUR 561,000 | PIC (1.00) |
| Fundacion Para la Investigacion Biomedica del Hospital Universitario 12 de Octubre | ESSpain | Third party | Not stated | known name (0.97) |
| Servicio Madrileno de Salud | ESSpain | Participant | EUR 242,500 | known name (0.97) |
| Artur | FRFrance | Participant | EUR 0 | PIC (1.00) |
| Centre Hospitalier Universitaire de Rennes | FRFrance | Participant | EUR 526,506 | known name (0.95) |
| Gustave Roussy Transfert | FRFrance | Third party | Not stated | PIC (1.00) |
| Primaa | FRFrance | Participant | EUR 193,125 | PIC (1.00) |
| Resilience | FRFrance | Participant | EUR 152,500 | PIC (1.00) |
| Queen Mary University of London | GBUnited Kingdom | Associated partner | EUR 0 | PIC (1.00) |
| Fondazione Irccs Istituto Nazionale Dei Tumori | ITItaly | Participant | EUR 371,250 | known name (0.95) |
| Stichting het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis | NLNetherlands | Participant | EUR 280,650 | known name (0.95) |
| Stichting Ikcc | NLNetherlands | Participant | EUR 46,875 | PIC (1.00) |
Changes of the consortium
First seen on with 16 participants from 8 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.